Harold C. Kluender
Bayer (United States)(US)Bayer (Germany)(DE)
Publications by Year
Research Areas
Asymmetric Synthesis and Catalysis, Chemical Synthesis and Analysis, Asthma and respiratory diseases, Neurotransmitter Receptor Influence on Behavior, Antibiotic Resistance in Bacteria
Most-Cited Works
- → Synthesis and incorporation of (2S,3S)-valine-4 13C into .beta.-lactam antibiotics(1973)67 cited
- → In vitro SAR of (5-(2H)-isoxazolonyl) ureas, potent inhibitors of hormone-sensitive lipase(2004)60 cited
- → Synthesis of dl-hedycaryol(1972)36 cited
- → The binding of [3H]leukotriene C4 to guinea-pig lung membranes. The lack of correlation of LTC4 functional activity with binding affinity(1987)33 cited
- → Incorporation of (2S,3R)-[4,4,4-2H3]valine and (2S,3S)-[4,4,4-2H3]valine into .beta.-lactam antibiotics(1974)30 cited
- → Conformational isomerism in dihydropregeijerene and hedycaryol(1973)28 cited
- → Constrained analogs of CB-1 antagonists: 1,5,6,7-Tetrahydro-4H-pyrrolo[3,2-c]pyridine-4-one derivatives(2006)26 cited
- → A new structural analogue antagonist of peptido-leukotrienes. The discovery of bay x7195(1993)22 cited
- → Optimization of imidazole amide derivatives as cannabinoid-1 receptor antagonists for the treatment of obesity(2007)14 cited
- → SAR of a novel ‘Anthranilamide Like’ series of VEGFR-2, multi protein kinase inhibitors for the treatment of cancer(2007)11 cited